North Carolina Nephrology offers clinical trials. We are currently enrolling participants in clinical trials for:
- IMAGINATION for IgA Nephropathy – Raleigh Location: Monthly injection of an investigational medication for IgA nephropathy (IgAN) to reduce protein leakage and slow disease progression.
- CSL – Cary office, Southwest Wake and Cary Dialysis clinics: Monthly intravenous (IV) injection of an investigational drug to reduce inflammation and cardiovascular events in hemodialysis patients who have a history of diabetes or atherosclerotic heart disease.
- Vertex Amplified – Cary Office: One tablet daily of an investigational drug in an open-label study targeting those with APOL 1 Mediated Kidney Disease (AMKD). Includes those with and without other diagnosis that may contribute to Chronic Kidney Disease. (i.e. Diabetes, Lupus Nephritis, Sickle Cell Disease, HIV, and Mild to Severe Proteinuria).
- Vertex Amplitude – Cary Office: One tablet daily of an investigational drug to see if it will slow or stop the worsening of kidney function as well as target the underlying APOL1-mediated chronic kidney disease.
A clinical trial is also called a research study. Under the supervision of a medical doctor and other research professionals, volunteers receive investigational treatments.
If you are interested in being a participate in one of these clinical trials, please use the contact form below.